Pages

• About Us
  • Our Partners
  • Our Programs
    • Molecular Screening & Therapeutics (MoST) Study
      • MoST Substudies
    • Genetic Cancer Risk in the Young (RisC) study
    • Surveillance study in Multi-Organ Cancer prone syndromes (SMOC+)
  • Our Network
    • Our sites
  • Our board
  • Leadership team
  • Publications
    • Annual reports
• Clinicians
• Contact Us
• FAQ
• Industry
• News
• Omico – Outsmarting Cancer Together
• Patients and Families
• Privacy Policy
• Researchers
• Sitemap

News

• Making a difference
• Masterclass webinar series - Demystifying the Molecular Tumour Board
• How cancer develops resistance to treatment
• A reflection on cancer
• Australian Government & Roche co-fund the ‘ASPiRATION’ lung cancer study
• Access to clinical trials crucial for Australians living with rare or uncommon cancers
• Ground-breaking trial brings personalised treatments to those with rare cancers
• Ground breaking trial